A conserved NR5A1-responsive enhancer regulates SRY in testis-determination.
Denis HouzelsteinCaroline EozenouCarlos F LagosMaëva ElzaiatJoelle Bignon-TopalovicInma GonzalezVincent LavilleLaurène SchlickSomboon WankanitProchi MadonJyotsna KirtaneArundhati AthalyeFederica BuonocoreStéphanie BigouGerard S ConwayDelphine BohlJohn C AchermannAnu BashambooKenneth McElreaveyPublished in: Nature communications (2024)
The Y-linked SRY gene initiates mammalian testis-determination. However, how the expression of SRY is regulated remains elusive. Here, we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY expression to initiate testis-determination in humans. Comparative sequence analysis of SRY 5' regions in mammals identified an evolutionary conserved SF-1/NR5A1-binding motif within a 250 bp region of open chromatin located 5 kilobases upstream of the SRY transcription start site. Genomic analysis of 46,XY individuals with disrupted testis-determination, including a large multigenerational family, identified unique single-base substitutions of highly conserved residues within the SF-1/NR5A1-binding element. In silico modelling and in vitro assays demonstrate the enhancer properties of the NR5A1 motif. Deletion of this hemizygous element by genome-editing, in a novel in vitro cellular model recapitulating human Sertoli cell formation, resulted in a significant reduction in expression of SRY. Therefore, human NR5A1 acts as a regulatory switch between testis and ovary development by upregulating SRY expression, a role that may predate the eutherian radiation. We show that disruption of an enhancer can phenocopy variants in the coding regions of SRY that cause human testis dysgenesis. Since disease causing variants in enhancers are currently rare, the regulation of gene expression in testis-determination offers a paradigm to define enhancer activity in a key developmental process.
Keyphrases
- transcription factor
- binding protein
- poor prognosis
- dna binding
- gene expression
- endothelial cells
- solid phase extraction
- copy number
- genome editing
- molecularly imprinted
- crispr cas
- genome wide
- genome wide identification
- germ cell
- dna methylation
- stem cells
- long non coding rna
- pluripotent stem cells
- high throughput
- cell therapy
- minimally invasive
- drug delivery
- cancer therapy
- radiation induced
- liquid chromatography
- amino acid